Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibition in Oncology”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Early research (Phase 1)Study completedNCT00019565
What this trial is testing

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 53
Not applicableUnknownNCT03567135
What this trial is testing

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Who this might be right for
Glioblastoma
Fuzhou General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00866697
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 940
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00083382
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 83
Testing effectiveness (Phase 2)Study completedNCT01497704
What this trial is testing

Dose-Escalation and Safety Trial of YN968D1

Who this might be right for
Cancer Patients With Solid Tumors
Elevar Therapeutics 55
Testing effectiveness (Phase 2)Study completedNCT00108069
What this trial is testing

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Who this might be right for
Glioma
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)UnknownNCT03461185
What this trial is testing

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Large-scale testing (Phase 3)Study completedNCT00334282
What this trial is testing

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 435
Large-scale testing (Phase 3)Study completedNCT00312819
What this trial is testing

Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hadassah Medical Organization 60
Testing effectiveness (Phase 2)Looking for participantsNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Testing effectiveness (Phase 2)Study completedNCT03577743
What this trial is testing

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast CancerSafety IssuesEfficacy
Assiut University 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06563947
What this trial is testing

Single Arm Clinical Trial (Gut Microbiota and HCC)

Who this might be right for
Liver Cancer
Xu Yong, MD 30
Not applicableStudy completedNCT07053202
What this trial is testing

TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 140
Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Testing effectiveness (Phase 2)Study completedNCT01553188
What this trial is testing

AMG 386 and Abiraterone for Advanced Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate CancerNeoplasm, Prostate+1 more
National Cancer Institute (NCI) 36
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)Study completedNCT00219557
What this trial is testing

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Pfizer 111
Load More Results